in MEDLINE, Embase, and the Cochrane Database of Systematic Reviews without language limitation, the last search being updated in July 2012. The reference lists were hand searched for other relevant publications. Studies that determined the distribution of the GABRG2 rs211037 genotype in unrelated epilepsy patients and healthy controls were eligible for inclusion in the meta-analysis.
Data extraction
Publications were eligible for meta-analysis if they met the following inclusion criteria: (a) study had been done in epilepsy patients and controls; (b) genotype frequency data were available for both case and control groups; and (c) genotype distribution complied with Hardy-Weinberg equilibrium (after retesting in this meta-analysis). Major exclusion criteria were as follows:
(a) controls were related to patients; (b) data duplicated those of previous publications. The following characteristics were collected from each study: first author's surname, year of publication, ethnicity of patients, numbers of epilepsy patients and of controls with each genotype, and type of epilepsy.
Statistical analysis
The per-allele odds ratios (OR) of the rare allele (T) as well as the corresponding 95% confidence intervals (CI) and p values were calculated to compare epilepsy patients and controls. Codominant (C/C vs. T/T and C/T vs. T/T), dominant (C/C + C/T vs. T/T), and recessive (C/C vs. C/T + T/T) models were also tested. Subsidiary meta-analyses were performed to evaluate the above models on FS, IGE, or all studies. To measure the strength of genetic C/C  C/T  T/T  C  T   P  C  P  C  P  C  P  C  P  C  P  C   1  Kananura et al.  2002 German  IAE  ILAE  IGE  135 154  83 104  47  42  5  8  213 250  57 
Results
Characteristics of the included studies are listed in Table 1 . The initial search with the keywords and the subject terms identified 51 abstracts, all published in English. Of these abstracts, 27 were excluded because they were irrelevant to rs211037 or to epilepsy. In the next step, the full texts of the 24 remaining articles were evaluated, yielding eight, including 3258 subjects (1871 epilepsy patients and 1387 controls) that met our eligibility criteria for metaanalysis (Fig. 2) . Amongst the included studies, only three reportstwo Taiwanese 13, 17 and one Egyptian
18
-were associated with susceptibility to FS or IGE.
There was a considerable diversity of epilepsy types among the eight included studies. [11] [12] [13] [14] [15] [16] [17] [18] The control group in the Taiwanese   Table 2 Meta-analysis of GABRG2 rs211037 and susceptibility to FS, IGE, and all epilepsies under alternative genetic models. 12 and Chou et al. 16 were the same, only one control group was included in this meta-analysis. studies was shared, therefore only one control group of the two studies was included in the meta-analysis of all studies (Table 2 and Fig. 3) . 13, 17 Studies were classified into two categories: FS (6 studies: 535 patients vs. 1040 controls) [13] [14] [15] [16] 18 and IGE (4 studies:
407 patients vs. 850 controls). In one report, patients had either FS or IGE, hence that study was split and included in either FS or IGE meta-analyses. 15 Meta-analysis data of FS, IGE, and all studies are shown in Table  2 . Neither allele nor genotype association was observed with IGE or with all epilepsy (Table 2 and Fig. 3 ). However, significant association with FS existed under codominant (Fig. 4, TT in the autosomal recessive model (all studies, I 2 = 64%, p = 0.02). In the IGE category, heterogeneity was significant in the allele (all studies, I 2 = 68%, p = 0.03), codominant (TT vs. CC, all studies, I 2 = 63%, p = 0.04; TT vs. CT, all studies, I 2 = 59%, p = 0.06; Caucasian studies, I 2 = 63%, p = 0.07) and dominant (all studies, I 2 = 63%, p = 0.05) models ( Table 2 ). The funnel plot for T vs. C in all studies was basically symmetric, and Egger's test did not indicate statistically significant asymmetry of the plot (intercept = À1.85, 95% CI À7.68-3.97, p = 0.47), suggesting no evidence of publication bias.
Discussion
Of eight reports, three supported the hypothesis that the synonymous GABRG2 rs211037 polymorphism is a risk factor for epilepsy: one study in Egypt for susceptibility to FS and two studies in Taiwan for susceptibility to FS or IGE. Meta-analysis showed significant association between rs211037 and FS under co-dominant and dominant genotype models, with the Egyptian and/or Taiwanese studies contributing much of the significance. However, meta-analysis did not show significant association between IGE and either alleles or genotypes. It is plausible that the association with FS is either a true positive or a false positive obtained by chance.
Ethnicity might explain the association with FS. The prevalence of variants and linkage disequilibrium with other risk-associated variants varies among geographical populations. This genetic difference interacts with environmental factors such as regional climate, culture, and pathogens and results in a variety of adaptations of populations or individuals. [21] [22] [23] The incidence of FS varies in the world. In Western Europe and USA, the incidence of FS is less than Asia (2-5% vs. 5-10% in India, and 9% in Japan). 24 In this study, the CC genotype in the Asians with FS was more frequent than in controls (23 and 14%, respectively), while it did not differ between Caucasians with FS and controls (44 and 45%, respectively). It is possible that the CC genotype acts as a causal factor for susceptibility to FS in Asians (Chinese and Egyptians) but not in Caucasians due to differences in environment, genetic background, or linkage disequilibrium of rs211037 with other variants contributing to epilepsy risk. Verification of this finding awaits future studies. On the other hand, the results of the Taiwanese and Egyptian FS studies may be false due to small sample size and uncontrolled genotyping quality phenomena. Sample size is a crucial determinant of the power to detect a causal variant in genetic association studies of multi-factorial polygenic diseases. To increase the power of these studies, large sample sizes are needed to give enough power for identifying the common causal loci with small effect sizes. 25, 26 The range of sample sizes within the 6 FS association studies was 187-414 (mean = 263). Of the two FS studies with significant association, one had the minimum subject number (187) and the other had less than the average sample size (220). 13, 18 Rigorous quality control (QC) is a crucial component of association studies since subtle biases in raw data can produce false positives. 27 In the FS group, the three studies with significant association used the same method and protocol for genotype analysis (polymerase chain reaction-restriction fragment length polymorphism or PCR-RFLP), 13, 17, 18 while the studies with opposite results used single-strand confirmation polymorphism (SSCP) analysis or Applied Biosystems Taqman technology. [14] [15] [16] The three articles with significant association did not state whether they controlled the PCR-RFLP product quality by other techniques, however the studies that used SSCP or Taqman technology duplicated some genotype data by other techniques. A replication stage using alternative standard methods is a key factor in controlling genotype quality and reducing false positive results. 27 However, despite of doing QC for genotyping; the error of some techniques such as SSCP cannot be ignored. For example, a study which was performed in European American samples, reported a very low frequency of minor allele frequency in both cases and controls (0.007 and 0.02, respectively). 16 Some limitations of our meta-analysis should be acknowledged. First, the criteria for the selection of patients and controls in the included studies were heterogeneous for parameters such as definitions for FS, seizure type, and family history of FS. There are two definitions of FS, published by the National Institute of Health (NIH) and the International League Against Epilepsy (ILAE). The NIH and ILAE definitions are very similar, but they differ in the lower age limit (three vs. one month, respectively). 24 Among the six studies of FS, four used the ILAE definition of FS. 13, 15, 18 14 and 100% of FS patients, 16 but the remaining studies did not report the family history of FS patients. Second, the small number of studies of Caucasians with FS and Asians with IGE made it impossible to perform a complete stratified analysis by ethnicity. Third, the two Taiwanese studies used the same controls in their analysis. In conclusion, despite significant association between the GABRG2 rs211037 polymorphism and susceptibility to FS, a possible false positive result cannot be excluded. Future studies with larger sample sizes are required to verify the results.
